Thieno-Thiazolostilbenes, Thienobenzo-Thiazoles, and Naphtho-Oxazoles: Computational Study and Cholinesterase Inhibitory Activity.
1,3-oxazole
1,3-thiazole
cholinesterase inhibition
electronic structure
molecular docking
thiophene
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
27 Apr 2023
27 Apr 2023
Historique:
received:
31
03
2023
revised:
25
04
2023
accepted:
26
04
2023
medline:
15
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
Naphtho-triazoles and thienobenzo-triazoles have so far proven to be very potent inhibitors of the enzyme butyrylcholinesterase (BChE). Based on these results, in this work, new thienobenzo-thiazoles were designed and synthesized, and their potential inhibitory activity was tested and compared with their analogs, naphtho-oxazoles. The synthesis was carried out by photochemical cyclization of thieno-thiazolostilbenes obtained in the first reaction step. Several thienobenzo-thiazoles and naphtho-oxazoles have shown significant potential as BChE inhibitors, together with the phenolic thiazolostilbene being the most active of all tested compounds. These results are significant as BChE has been attracting growing attention due to its positive role in the treatment of Alzheimer's disease. Computational examination based on the DFT approach enabled the characterization of the geometry and electronic structure of the studied molecules. Furthermore, the molecular docking study, accompanied by additional optimization of complexes ligand-active site, offered insight into the structure and stabilizing interactions in the complexes of studied molecules and BChE.
Identifiants
pubmed: 37175190
pii: molecules28093781
doi: 10.3390/molecules28093781
pmc: PMC10180155
pii:
doi:
Substances chimiques
Butyrylcholinesterase
EC 3.1.1.8
Thiazoles
0
Oxazoles
0
Cholinesterase Inhibitors
0
Acetylcholinesterase
EC 3.1.1.7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Drug Res (Stuttg). 2015 Apr;65(4):176-83
pubmed: 24918348
Curr Drug Targets. 2003 Jan;4(1):1-11
pubmed: 12528985
Prog Neurobiol. 1993 Jul;41(1):31-91
pubmed: 8321908
Eur J Med Chem. 2000 Jun;35(6):635-41
pubmed: 10906414
CNS Neurol Disord Drug Targets. 2014;13(8):1432-9
pubmed: 25345511
Molecules. 2022 Feb 02;27(3):
pubmed: 35164276
Bioorg Chem. 2022 Apr;121:105701
pubmed: 35228009
Bioorg Med Chem. 2009 Jan 15;17(2):882-95
pubmed: 19084415
Eur J Med Chem. 2009 Dec;44(12):4944-53
pubmed: 19740574
Molecules. 2022 Sep 27;27(19):
pubmed: 36234916
Curr Top Med Chem. 2016;16(26):2841-2862
pubmed: 27150376
Comb Chem High Throughput Screen. 2016;19(1):51-7
pubmed: 26632442
J Comput Chem. 2003 Apr 30;24(6):669-81
pubmed: 12666158
Molecules. 2021 Mar 07;26(5):
pubmed: 33800023
Bioorg Med Chem Lett. 2007 Jul 15;17(14):4022-5
pubmed: 17544669
Arch Pharm (Weinheim). 2019 Jan;352(1):e1800170
pubmed: 30488989
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Molecules. 2022 Sep 18;27(18):
pubmed: 36144820
J Enzyme Inhib Med Chem. 2013 Apr;28(2):240-66
pubmed: 23030043
Int J Mol Sci. 2022 Dec 29;24(1):
pubmed: 36614053
Int J Mol Sci. 2023 Mar 20;24(6):
pubmed: 36982951
Eur J Med Chem. 2022 Nov 5;241:114616
pubmed: 35870364
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518